CogNet AI-MT+
Advanced AI mammography triage system with FDA clearance
Software · HybridCompany source
Company profile
About MedCognetics
MedCognetics is a medical imaging AI company specializing in breast cancer detection and lung screening solutions. The company's flagship product, CogNet Mammo, uses artificial intelligence to assist radiologists by flagging suspicious mammograms and enabling case triage based on findings. This approach helps address critical challenges in radiology including workforce shortages, heavy workloads, and burnout. The company has developed its AI systems through global collaboration, sourcing diverse patient data from around the world to create unbiased detection algorithms. MedCognetics' technology aims to improve early breast cancer detection, which is critical since mortality largely depends on cancer stage at diagnosis. The company offers flexible deployment options including embedded AI systems and proprietary tools that integrate into existing radiology workflows. Their solutions serve regions where radiologists cannot meet screening population demands, with a particular focus on underserved communities. MedCognetics has received FDA clearance for its CogNet AI-MT+ system and has secured NIH grant funding for research into unbiased artificial intelligence for breast cancer detection. The company partners with healthcare organizations globally to expand access to AI-assisted cancer screening.
Company description MedCognetics official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at MedCognetics?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- breast cancer
- lung cancer
Who it serves
- Health Systems
- Mobile Clinics
- Radiology Practices
Deployment & integration
Embedded · Hybrid deployment with recorded integration context.
Recorded integration context: Laurel Bridge Software.
Geographic context
MarketsIndia · Nigeria · Qatar · underserved communities globally · United Kingdom · United States
Company sourceOfficial website
Company milestones
Platform expansion
FDA clearance for CogNet AI-MT+ (February 2026), partnership with AWS for underserved communities (May 2026), deployment in India through AKARUI Solutions (August 2025), embedded AI system introduction (October 2024)
Partnerships
Recorded partners
- AKARUI Solutions
- AMD
- AWS
- Laurel Bridge Software
- University of Texas at Dallas
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
CogNet Lung
AI system for lung imaging analysis
Software · HybridCompany source
CogNet Mammo
AI-powered mammography screening system for early breast cancer detection
Software · HybridCompany source
Embedded AI
Integrated AI system for seamless deployment in existing radiology workflows
Software · EmbeddedCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Faster super-resolution ultrasound imaging with a deep learning model for tissue decluttering and contrast agent localization.Biomedical physics & engineering express · Oct 25, 2021
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
CogNet AI-MT+K252482 · 510k · Dec 11, 2025
CogNet QmTRIAGEK220080 · 510k · Sep 29, 2022
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Early breast cancer detection
Aims to detect breast cancer as early as possible to decrease mortality
Workflow efficiency
Increases efficiency and accuracy by allowing radiologists to manage workflow and triage cases
Radiologist burnout reduction
Empowers radiologists to prioritize flagged cases, addressing shortages and heavy workloads
AWS Partnership
Bringing AI-powered breast cancer screening to underserved communities through cloud infrastructure
Expanded access to AI screening in underserved communities
Laurel Bridge Software Partnership
Providing secure AI deployment for medical imaging through partnership integration
Enhanced security for AI-powered medical imaging workflows
AMD Partnership
Transforming healthcare with AI through hardware optimization and deployment
Improved AI performance and deployment capabilities in healthcare settings
AKARUI Solutions
Deployment of MedCognetics' AI for breast cancer screening in India, including rural communities through mobile clinics
Bringing AI-powered breast cancer screening to underserved rural communities in India
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Debasish "Ron" Nag
Chief Executive Officer
Paula Gupta
Chief Clinical Development Officer
Tim Cogan
Chief Technology Officer
Vasant Garg
Chief Medical Officer
Chris Beaty
Vice President of Operations
John Jenkins
Chief Quality Officer
Chase Waggener
AI Development Lead
Lakshman Tamil
Co-Founder & Professor
06 · Company updates
Updates from MedCognetics
Recent articles published on MedCognetics's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.